Diana Lizbeth de la Cruz Ramirez

Dr. Diana Lizbeth de la Cruz Ramirez

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2022 in Journal of General Physiology
Verified
Journal Article
Open access
PDF file
JJJill B. Jensen
Jill B. Jensen
BFBjoern H. Falkenburger
Bjoern H. Falkenburger
EDEamonn J. Dickson
Eamonn J. Dickson
DRDiana Lizbeth de la Cruz Ramirez
Diana Lizbeth de la Cruz Ramirez
GDGucan Dai
Gucan Dai
BHBertil Hille
Bertil Hille
Phosphoinositide membrane lipids are ubiquitous low-abundance signaling molecules. They direct many physiological processes that involve ion channels, membrane identification, fusion of membrane vesicles, and vesicular endocytosis. Pools of these lipids are continually broken down and refilled in living cells, and the rates of some of these reactions are strongly accelerated by physiological stimuli. Recent biophysical experiments described here measure and model the kinetics and regulation of these lipid signals in intact cells. Rapid on-line monitoring of phosphoinositide metabolism is made possible by optical tools and electrophysiology. The experiments reviewed here reveal that as for other cellular second messengers, the dynamic turnover and lifetimes of membrane phosphoinositides are measured in seconds, controlling and timing rapid physiological responses, and the signaling is under strong metabolic regulation. The underlying mechanisms of this metabolic regulation remain questions for the future.

1 October 2016 in American Journal of Physiology-Cell Physiology
Verified
Journal Article
Closed access
PDF file
DRDiana Lizbeth de la Cruz Ramirez
Diana Lizbeth de la Cruz Ramirez
EPErika I. Puente
Erika I. Puente
ARArturo Reyes-Vaca
Arturo Reyes-Vaca
IAIsabel Arenas
Isabel Arenas
JGJulieta Garduño
Julieta Garduño
DGDavid E Garcia
David E Garcia
Phosphatidylinositol-4,5-bisphosphate (PIP2) is a membrane phosphoinositide that regulates the activity of many ion channels. Influx of calcium primarily through voltage-gated calcium (CaV) channels promotes insulin secretion in pancreatic β-cells. However, whether CaV channels are regulated by PIP2, as is the case for some non-insulin-secreting cells, is unknown. The purpose of this study was to investigate whether CaV channels are regulated by PIP2 depletion in pancreatic β-cells through activation of a muscarinic pathway induced by oxotremorine methiodide (Oxo-M). CaV channel currents were recorded by the patch-clamp technique. The CaV current amplitude was reduced by activation of the muscarinic receptor 1 (M1R) in the absence of kinetic changes. The Oxo-M-induced inhibition exhibited the hallmarks of voltage-independent regulation and did not involve PKC activation. A small fraction of the Oxo-M-induced CaV inhibition was diminished by a high concentration of Ca2+ chelator, whereas ≥50% of this inhibition was prevented by diC8-PIP2 dialysis. Localization of PIP2 in the plasma membrane was examined by transfecting INS-1 cells with PH-PLCδ1, which revealed a close temporal association between PIP2 hydrolysis and CaV channel inhibition. Furthermore, the depletion of PIP2 by a voltage-sensitive phosphatase reduced CaV currents in a way similar to that observed following M1R activation. These results indicate that activation of the M1R pathway inhibits the CaV channel via PIP2 depletion by a Ca2+-dependent mechanism in pancreatic β- and INS-1 cells and thereby support the hypothesis that membrane phospholipids regulate ion channel activity by interacting with ion channels.

1 June 2019 in Neuroscience Letters
Verified
Journal Article
Closed access
JGJulieta Garduño
Julieta Garduño
SHSalvador Hernández-López
Salvador Hernández-López
DRDiego Castillo Rolón
Diego Castillo Rolón
DRDiana Lizbeth de la Cruz Ramirez
Diana Lizbeth de la Cruz Ramirez
FHFabiola Hernández-Vázquez
Fabiola Hernández-Vázquez
DGDavid E. Garcia
David E. Garcia

1 August 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
PLPavel Lugo
Pavel Lugo
LOLeslie M. Otero-Sastre
Leslie M. Otero-Sastre
JBJohanna Bernáldez-Sarabia
Johanna Bernáldez-Sarabia
Tanya Camacho-VillegasTanya Camacho-Villegas
Tanya Camacho-Villegas
LCL. Noemi Sanchez Campos
L. Noemi Sanchez Campos
Alexei Fedorovish Licea-NavarroAlexei Fedorovish Licea-Navarro
Alexei Fedorovish Licea-Navarro
The FDA’s approval of peptide drugs such as Ziconotide or Exendin for pain relief and diabetes treatment, respectively, enhanced the interest to explore novel conotoxins from Conus species venom. In general, conotoxins can be used in pathologies where voltage-gated channels, membrane receptors, or ligands alter normal physiological functions, as in metabolic diseases such as Type 2 diabetes. In this study, the synthetic cal14.2b (s-cal14.2b) from the unusual Californiconus californicus demonstrated bioactivity on NIT-1 insulinoma cell lines stimulating insulin secretion detecting by high performance liquid chromatography (HPLC). Accordingly, s-cal14.2b increased the CaV1.2/1.3 channel-current by 35 ± 4% with a recovery τ of 10.3 ± 4 s in primary cell culture of rat pancreatic β-cells. The in vivo results indicated a similar effect of insulin secretion on mice in the glucose tolerance curve model by reducing the glucose from 500 mg/dL to 106 mg/dL in 60 min, compared to the negative control of 325 mg/dL at the same time. The PET-SCAN with radiolabeling 99mTc-s-cal14.2b demonstrated biodistribution and accumulation in rat pancreas with complete depuration in 24 h. These findings show the potential therapeutic use of s-cal14.2b in endocrinal pathologies such as early stages of Type 2 Diabetes where the pancreas’s capability to produce insulin is still effective.

15 January 2020 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
DRDiana Lizbeth de la Cruz Ramirez
Diana Lizbeth de la Cruz Ramirez
ATAlexis Traynor-Kaplan
Alexis Traynor-Kaplan
OVOscar Vivas
Oscar Vivas
BHBertil Hille
Bertil Hille
JJJill B. Jensen
Jill B. Jensen
Phosphoinositide lipids regulate many cellular processes and are synthesized by lipid kinases. Type I phosphatidylinositol phosphate 5-kinases (PIP5KIs) generate phosphatidylinositol 4,5-bisphosphate [PtdIns(4,5)P2]. Several phosphoinositide-sensitive readouts revealed the nonequivalence of overexpressing PIP5KIβ, PIP5KIγ or Ras association domain family 4 (RASSF4), believed to activate PIP5KIs. Mass spectrometry showed that each of these three proteins increased total cellular phosphatidylinositol bisphosphates (PtdInsP2) and trisphosphates (PtdInsP3) at the expense of phosphatidylinositol phosphate (PtdInsP) without changing lipid acyl chains. Analysis of KCNQ2/3 channels and PH domains confirmed an increase in plasma membrane PtdIns(4,5)P2 in response to PIP5KIβ or PIP5KIγ overexpression, but RASSF4 required coexpression with PIP5KIγ to increase plasma membrane PtdIns(4,5)P2. Effects on the several steps of store-operated calcium entry (SOCE) were not explained by plasma membrane phosphoinositide increases alone. PIP5KIβ and RASSF4 increased STIM1 proximity to the plasma membrane, accelerated STIM1 mobilization and speeded onset of SOCE; however, PIP5KIγ reduced STIM1 recruitment but did not change induced Ca2+ entry. These differences imply actions through different segregated pools of phosphoinositides and specific protein–protein interactions and targeting. This article has an associated First Person interview with the first author of the paper.

18 February 2022 in Journal of General Physiology
Verified
Journal Article
Open access
PDF file
DRDiana Lizbeth de la Cruz Ramirez
Diana Lizbeth de la Cruz Ramirez
CKChristopher Kushmerick
Christopher Kushmerick
JSJane M. Sullivan
Jane M. Sullivan
MKMartin Kruse
Martin Kruse
OVOscar Vivas
Oscar Vivas
PtdIns(4,5)P2 is a signaling lipid central to the regulation of multiple cellular functions. It remains unknown how PtdIns(4,5)P2 fulfills various functions in different cell types, such as regulating neuronal excitability, synaptic release, and astrocytic function. Here, we compared the dynamics of PtdIns(4,5)P2 synthesis in hippocampal neurons and astrocytes with the kidney-derived tsA201 cell line. The experimental approach was to (1) measure the abundance and rate of PtdIns(4,5)P2 synthesis and precursors using specific biosensors, (2) measure the levels of PtdIns(4,5)P2 and its precursors using mass spectrometry, and (3) use a mathematical model to compare the metabolism of PtdIns(4,5)P2 in cell types with different proportions of phosphoinositides. The rate of PtdIns(4,5)P2 resynthesis in hippocampal neurons after depletion by cholinergic or glutamatergic stimulation was three times faster than for tsA201 cells. In tsA201 cells, resynthesis of PtdIns(4,5)P2 was dependent on the enzyme PI4K. In contrast, in hippocampal neurons, the resynthesis rate of PtdIns(4,5)P2 was insensitive to the inhibition of PI4K, indicating that it does not require de novo synthesis of the precursor PtdIns(4)P. Measurement of phosphoinositide abundance indicated a larger pool of PtdIns(4)P, suggesting that hippocampal neurons maintain sufficient precursor to restore PtdIns(4,5)P2 levels. Quantitative modeling indicates that the measured differences in PtdIns(4)P pool size and higher activity of PI4K can account for the experimental findings and indicates that high PI4K activity prevents depletion of PtdIns(4)P. We further show that the resynthesis of PtdIns(4,5)P2 is faster in neurons than astrocytes, providing context to the relevance of cell type–specific mechanisms to sustain PtdIns(4,5)P2 levels.